Abstract:Cardiovascular disease (CVD) remains the leading cause of death in Western countries despite improvements in prevention, diagnosis and treatment. Atherosclerosis is a chronic inflammatory disease that remains clinically silent for many decades. Sudden rupture of “high-risk/vulnerable” plaques has been shown to be responsible for the majority of acute cardiovascular events, including myocardial infarction and stroke. Therefore, early detection of biological processes associated with atherosclerosis progression and plaque instability may improve diagnosis and treatment and help to better monitor the effectiveness of therapeutic interventions. Molecular magnetic resonance imaging (MRI) is a promising tool to detect molecular and cellular changes in the carotid, aortic and coronary vessel wall including endothelial dysfunction, inflammation, vascular remodelling, enzymatic activity, intraplaque haemorrhage and fibrin deposition and thus may allow early detection of unstable lesions and improve the prediction of future coronary events. Evaluation of atherosclerosis at both, the preclinical and clinical level includes non-contrast-enhanced (NCE) and contrast-enhanced (CE) MRI with and without the use of MR contrast agents. To increase the biological information obtained by MRI a variety of targeted-specific molecular probes have been developed for the non-invasive visualization of particular biological processes at the molecular and cellular level. This review will discuss the recent advances in molecular MRI of atherosclerosis, covering both pulse sequence development and also the design of novel contrast agents, for imaging atherosclerotic disease in vivo.

Intravascular molecular imaging: translating pathophysiology of atherosclerosis into human disease conditions

Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology

Atherosclerosis imaging on the molecular level

What does the future hold for novel intravascular imaging devices: a focus on morphological and physiological assessment of plaque

Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis

Intravascular Molecular Imaging: Near-Infrared Fluorescence as a New Frontier

Molecular Imaging and Non-molecular Imaging of Atherosclerotic Plaque Thrombosis

Reliable in vivo intravascular imaging plaque characterization: A challenge unmet

Recent Advances in Molecular Imaging of Atherosclerotic Plaques and Thrombosis

Multimodal intravascular imaging technology for characterization of atherosclerosis

Current Development of Molecular Coronary Plaque Imaging using Magnetic Resonance Imaging towards Clinical Application

Molecular and Nonmolecular Imaging of Macrophages in Atherosclerosis

Invasive or non-invasive imaging for detecting high-risk coronary lesions?

The vascular biology of atherosclerosis and imaging targets

Targeted Imaging in Atherosclerosis.

Image-based Modeling for Better Understanding and Assessment of Atherosclerotic Plaque Progression and Vulnerability: Data, Modeling, Validation, Uncertainty and Predictions.

Novel imaging modalities for the identification of vulnerable plaques

Intravascular Imaging of Atherosclerosis by Using Engineered Nanoparticles

Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque

Uncovering atherosclerotic cardiovascular disease by PET imaging

Molecular imaging of atherosclerosis with integrated PET imaging